Company Filing History:
Years Active: 2022-2024
Title: Zoya Alteber: Innovator in Antibody Therapies
Introduction
Zoya Alteber is a prominent inventor based in Nes Ziyona, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of innovative antibody therapies. With a total of 2 patents, her work is paving the way for advancements in cancer treatment.
Latest Patents
Zoya's latest patents focus on triple combination antibody therapies. These inventions are directed towards utilizing anti-TIGIT antibodies, anti-PVRIG antibodies, and checkpoint inhibitors, including anti-PD-1 or anti-PD-L1 antibodies. This innovative approach aims to enhance the efficacy of cancer treatments by combining multiple therapeutic agents.
Career Highlights
Zoya Alteber is currently employed at Compugen Ltd. Corporation, where she continues to push the boundaries of scientific research and development. Her expertise in antibody therapies has positioned her as a key player in the biotechnology sector.
Collaborations
Zoya collaborates with talented individuals such as Spencer Liang and Ling Leung. These partnerships foster a dynamic environment for innovation and research, contributing to the success of their projects.
Conclusion
Zoya Alteber's work in antibody therapies exemplifies the impact of innovative thinking in biotechnology. Her contributions are vital to the ongoing development of effective cancer treatments.